EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer

Yao Lu, Ruiting Lan iD, Qianhua Fan, Huijing Tang, Dalong Hu, Shuwei Zhang, Xiaoying Lin, Ruoshi Wang, Ruiqing Zhao, Hui Sun, Liyun Liu, Jianguo Xu

The ISME Journal · 02.01.2025 · 19 (1)

DOI: 10.1093/ismejo/wraf130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The ISME Journal, online erschienen am 26.06.2025. Verfasst von Yao Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prev…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Microenvironment, Probiotics, Eubacterium. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Units of Discovery of Unknown Bacteria and Function.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota play a key role in ameliorating colorectal cancer (CRC). Eubacterium limosum is a potential probiotic with anti-CRC functions. However, the mechanistic basis of its anti-CRC effect remains largely unknown. In vitro, we detected the effects of the E. limosum strain El1405 on cell proliferation, colony formation, cell cycle, and apoptosis of CRC cells, and found that El1405CS specifically suppressed cell proliferation by altering cell cycle distribution and inducing apoptosis. In the CT26 syngeneic mouse model, daily gavage with live El1405, inactivated El1405, culture supernatant of El1405, and El1405-derived indole derivatives, including indole-3-lactic acid (ILA), indole-3-acetic acid (IAA), L-arginine, and butyrate, inhibited tumor growth. Analysis of the 16S rRNA gene sequences revealed that El1405 altered the microbiota compositions within tumors, primarily reducing the abundance of Enterobacter, Pseudomonas, and Staphylococcus. Staphylococcus succinus isolated from the tumors of CT26 syngeneic mice promoted abdominal metastasis of tumors. Moreover, El1405 intervention significantly increased the levels of TNF-α, INF-γ, and CD8 in the tumor microenvironment, while decreasing the levels of CD4, IL-6, IL-10, and TGF-β. Metabolomic analysis indicated that El1405 induced antitumor effects through changing the serum metabolome of mice by producing indole derivatives such as ILA and IAA. Furthermore, 16S rRNA gene sequencing demonstrated that El1405 intervention changed the composition of intestinal flora, significantly increasing the abundance of Roseburia and Eubacterium while decreasing the abundance of Staphylococcus and Enterococcus. These findings suggest that E. limosum El1405 is a potential probiotic candidate for the prevention of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTumor MicroenvironmentProbioticsEubacteriumAntineoplastic AgentsAnimalsMiceGastrointestinal MicrobiomeCell ProliferationRNA, Ribosomal, 16SCell Line, TumorApoptosisMice, Inbred BALB CHumansDisease Models, Animal

Stichwörter der Autor:innen

Eubacterium limosumcolorectal cancergut microbiotametabolitestumor microenvironment

Substanzen

Antineoplastic AgentsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102…
  • School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.
  • Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
  • Research Units of Discovery of Unknown Bacteria and Function, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Hebei Key Laboratory of Intractable Pathogens, Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang, Hebei 050011, China.

ORCID-Profile: Ruiting Lan

Förderung

  • Research Units of Discovery of Unknown Bacteria and Function

Zitieren

APA

Lu, Y., Lan, R., Fan, Q., Tang, H., Hu, D., Zhang, S., Lin, X., Wang, R., Zhao, R., Sun, H., Liu, L., & Xu, J. (2025). Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer. The ISME Journal, 19(1). https://doi.org/10.1093/ismejo/wraf130

Vancouver

Lu Y, Lan R, Fan Q, Tang H, Hu D, Zhang S, et al. Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer. The ISME Journal. 2025;19(1). doi:10.1093/ismejo/wraf130

BibTeX
@article{Lu2025,
  author = {Lu, Yao and Lan, Ruiting and Fan, Qianhua and Tang, Huijing and Hu, Dalong and Zhang, Shuwei and Lin, Xiaoying and Wang, Ruoshi and Zhao, Ruiqing and Sun, Hui and Liu, Liyun and Xu, Jianguo},
  title = {Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer},
  journal = {The ISME Journal},
  year = {2025},
  volume = {19},
  number = {1},
  doi = {10.1093/ismejo/wraf130}
}
Kostenlos starten →